cystic fibrosis

Why Vertex Pharmaceuticals' Shares Rose 2.8% in September
Motley Fool
Wed, 10/5/22 - 10:33 am
Vertex Pharmaceuticals
Trikafta
R&D
cystic fibrosis
Where Will Vertex Pharmaceuticals Be in 1 Year?
Motley Fool
Tue, 08/23/22 - 10:38 am
Vertex Pharmaceuticals
cystic fibrosis
kidney disease
Fueled by $111 Million, Sionna Therapeutics Takes Aim at Cystic Fibrosis
BioSpace
Tue, 04/19/22 - 11:48 pm
Sionna Therapeutics
funding
cystic fibrosis
Vertex Pharmaceuticals
OrbiMed
Vertex’s Robust Pipeline is Ramping Up for Another Big Year
BioSpace
Wed, 04/13/22 - 10:35 am
Vertex Pharmaceuticals
cystic fibrosis
sickle cell disease
type 1 diabetes
Vertex strikes agreement with Australia for cystic fibrosis pill, ending high-profile standoff
Endpoints
Mon, 03/28/22 - 10:19 am
Vertex Pharma
cystic fibrosis
Australia
Trikafta
New OrbiMed-backed biotech aims to replicate Vertex's wildly successful cystic fibrosis pills in other diseases
Endpoints
Tue, 02/8/22 - 10:10 am
Congruence Therapeutics
funding
OrbiMed
Vertex Pharmaceuticals
protein misfolding
cystic fibrosis
3 Clinical Trials to Watch in the First Half of 2022
Motley Fool
Sat, 01/22/22 - 02:20 pm
clinical trials
Pfizer
Arena Pharmaceuticals
etrasimod
Roche
Alzheimer's disease
gantenerumab
AbbVie
cystic fibrosis
JPM 2022: Vertex's Trikafta holds the line as company lays groundwork for gene editing launch
Fierce Pharma
Mon, 01/10/22 - 11:44 pm
Vertex Pharmaceuticals
cystic fibrosis
JPMHC 2022
Trikafta
Cystic fibrosis group partners with Moderna founder to find better, potentially curative treatments
BioPharma Dive
Wed, 11/3/21 - 11:44 pm
patient advocacy groups
Flagship Pioneering
Moderna Therapeutics
cystic fibrosis
Could This Drug Become Vertex Pharmaceuticals' Next Blockbuster?
Motley Fool
Tue, 11/2/21 - 10:44 am
Vertex Pharmaceuticals
cystic fibrosis
clinical trials
VX-880
type 1 diabetes
Boehringer Ingelheim Steps Up to the Plate for Cystic Fibrosis Patients
BioSpace
Tue, 10/19/21 - 10:59 pm
Boehringer Ingelheim
cystic fibrosis
BI 3720931
Oxford BioMedica
Atlas backs a longtime Vertex employee’s quest to bring CF success to numerous other diseases
Endpoints
Thu, 10/14/21 - 11:06 am
Vertex Pharmaceuticals
Atlas
cystic fibrosis
R&D
Vertex Wants To Prove It's Not Another Biotech One-Hit Wonder
Yahoo/Bloomberg
Wed, 10/6/21 - 10:59 am
Vertex Pharmaceuticals
cystic fibrosis
Kalydeco
Vertex Hopes to Channel CF Drug Successes into Other Therapies in the Pipeline
BioSpace
Fri, 07/30/21 - 11:22 am
Vertex Pharmaceuticals
earnings
cystic fibrosis
As Arrowhead falters, lungs remain a tough target for RNA drugs
BioPharma Dive
Wed, 07/7/21 - 11:00 am
RNA
Arrowhead
ARO-ENaC
cystic fibrosis
Arrowhead rocked by animal tox issues again, hitting the pause button on RNAi study in cystic fibrosis
Endpoints
Fri, 07/2/21 - 11:04 am
Arrowhead Pharmaceuticals
RNAi
animal research
cystic fibrosis
Vertex stops work on second rare disease drug after study results disappoint
BioPharma Dive
Thu, 06/10/21 - 11:36 pm
Vertex Pharmaceuticals
VX-864
cystic fibrosis
Translate’s investment case shifts fully to Covid-19
EP Vantage
Thu, 03/18/21 - 08:28 pm
Translate Bio
clinical trials
MRT5005
cystic fibrosis
Vertex's (VRTX) Trikafta NDA Gets Priority Review by FDA
Yahoo/Zacks.com
Wed, 01/27/21 - 08:03 pm
Vertex Pharmaceuticals
cystic fibrosis
priority revies
FDA
Trikafta
Savara says sayonara to pipeline programs, doubles down on Molgradex, cuts staff
Fierce Biotech
Sat, 12/12/20 - 02:24 pm
Savara
molgradex
layoffs
cystic fibrosis

Pages